Zobrazeno 1 - 10
of 23
pro vyhledávání: '"Valkenburg KC"'
Autor:
Vega DM; Friends of Cancer Research, Washington., Yee LM; National Cancer Institute, Bethesda., McShane LM; National Cancer Institute, Bethesda., Williams PM; Molecular Characterization Laboratory, Frederick National Lab for Cancer Research, Leidos Biomedical Research Inc., Frederick., Chen L; Molecular Characterization Laboratory, Frederick National Lab for Cancer Research, Leidos Biomedical Research Inc., Frederick., Vilimas T; Molecular Characterization Laboratory, Frederick National Lab for Cancer Research, Leidos Biomedical Research Inc., Frederick., Fabrizio D; Foundation Medicine Inc., Cambridge., Funari V; NeoGenomics Laboratories, Aliso Viejo, USA., Newberg J; Foundation Medicine Inc., Cambridge., Bruce LK; NeoGenomics Laboratories, Aliso Viejo, USA., Chen SJ; ACT Genomics, Taipei, Taiwan., Baden J; Bristol Myers Squibb Co., Princeton., Carl Barrett J; AstraZeneca Pharmaceuticals LP, Waltham, USA., Beer P; European Organisation for Research and Treatment of Cancer, Brussels, Belgium., Butler M; LGC Clinical Diagnostics, Gaithersburg., Cheng JH; ACT Genomics, Taipei, Taiwan., Conroy J; OmniSeq Inc., Buffalo., Cyanam D; Clinical Sequencing Division, Thermo Fisher Scientific, Ann Arbor., Eyring K; Intermountain Precision Genomics, St. George., Garcia E; Brigham and Women's Hospital, Boston, USA., Green G; Bristol Myers Squibb Co., Princeton., Gregersen VR; QIAGEN Inc, Aarhus, Denmark., Hellmann MD; Memorial Sloan Kettering Cancer Center, New York., Keefer LA; Personal Genome Diagnostics, Baltimore., Lasiter L; Friends of Cancer Research, Washington., Lazar AJ; The University of Texas MD Anderson Cancer Center, Houston., Li MC; National Cancer Institute, Bethesda., MacConaill LE; Brigham and Women's Hospital, Boston, USA., Meier K; Illumina Inc, Clinical Genomics, San Diego., Mellert H; Biodesix, Inc., Boulder., Pabla S; OmniSeq Inc., Buffalo., Pallavajjalla A; Johns Hopkins University, Baltimore., Pestano G; Biodesix, Inc., Boulder., Salgado R; European Organisation for Research and Treatment of Cancer, Brussels, Belgium., Samara R; QIAGEN Inc, Aarhus, Denmark., Sokol ES; Foundation Medicine Inc., Cambridge., Stafford P; Caris Life Sciences Inc, Phoenix, Arizona, USA., Budczies J; Institute of Pathology, University Hospital Heidelberg, Heidelberg, Germany., Stenzinger A; Institute of Pathology, University Hospital Heidelberg, Heidelberg, Germany., Tom W; Clinical Sequencing Division, Thermo Fisher Scientific, Ann Arbor., Valkenburg KC; Personal Genome Diagnostics, Baltimore., Wang XZ; EMD Serono Research and Development Institute, Inc., Billerica., Weigman V; Q Squared Solutions, Durham., Xie M; AstraZeneca Pharmaceuticals LP, Waltham, USA., Xie Q; General Dynamics Information Technology, Inc., Columbia, USA., Zehir A; Memorial Sloan Kettering Cancer Center, New York., Zhao C; Illumina Inc, Clinical Genomics, San Diego., Zhao Y; National Cancer Institute, Bethesda., Stewart MD; Friends of Cancer Research, Washington. Electronic address: mstewart@focr.org., Allen J; Friends of Cancer Research, Washington.
Publikováno v:
Annals of oncology : official journal of the European Society for Medical Oncology [Ann Oncol] 2024 Jan; Vol. 35 (1), pp. 145. Date of Electronic Publication: 2023 Aug 08.
Autor:
Verner EL; Personal Genome Diagnostics (PGDx), Baltimore, Maryland. Electronic address: everner@pgdx.com., Jackson JB; Personal Genome Diagnostics (PGDx), Baltimore, Maryland. Electronic address: jjackson@pgdx.com., Severson E; Enterprise Oncology, Labcorp, Durham, North Carolina., Valkenburg KC; Personal Genome Diagnostics (PGDx), Baltimore, Maryland., Greer AE; Personal Genome Diagnostics (PGDx), Baltimore, Maryland., Riley DR; Personal Genome Diagnostics (PGDx), Baltimore, Maryland., Sausen M; Personal Genome Diagnostics (PGDx), Baltimore, Maryland., Maddox C; Personal Genome Diagnostics (PGDx), Baltimore, Maryland., McGregor PM 3rd; Personal Genome Diagnostics (PGDx), Baltimore, Maryland., Karandikar A; Personal Genome Diagnostics (PGDx), Baltimore, Maryland., Hastings SB; Enterprise Oncology, Labcorp, Durham, North Carolina., Previs RA; Enterprise Oncology, Labcorp, Durham, North Carolina., Reddy VP; Enterprise Oncology, Labcorp, Durham, North Carolina., Jensen TJ; Enterprise Oncology, Labcorp, Durham, North Carolina., Ramkissoon SH; Enterprise Oncology, Labcorp, Durham, North Carolina.
Publikováno v:
The Journal of molecular diagnostics : JMD [J Mol Diagn] 2023 Jul; Vol. 25 (7), pp. 477-489. Date of Electronic Publication: 2023 Apr 15.
Autor:
Ghiaur G; Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, Baltimore, Maryland, USA., Valkenburg KC; Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, Baltimore, Maryland, USA., Esteb C; Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, Baltimore, Maryland, USA., Ambinder A; Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, Baltimore, Maryland, USA., Imus PH; Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, Baltimore, Maryland, USA., Pienta KJ; Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, Baltimore, Maryland, USA., Jones RJ; Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, Baltimore, Maryland, USA.
Publikováno v:
Cancer [Cancer] 2023 Jun 01; Vol. 129 (11), pp. 1744-1751. Date of Electronic Publication: 2023 Feb 25.
Autor:
van 't Erve I; Department of Pathology, The Netherlands Cancer Institute, Amsterdam, the Netherlands., Medina JE; Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, Maryland., Leal A; Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, Maryland., Papp E; Personal Genome Diagnostics, Baltimore, Maryland., Phallen J; Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, Maryland., Adleff V; Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, Maryland., Chiao EJ; Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, Maryland., Arun AS; Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, Maryland., Bolhuis K; Department of Medical Oncology, Amsterdam UMC, University of Amsterdam, Amsterdam, the Netherlands., Simmons JK; Personal Genome Diagnostics, Baltimore, Maryland., Karandikar A; Personal Genome Diagnostics, Baltimore, Maryland., Valkenburg KC; Personal Genome Diagnostics, Baltimore, Maryland., Sausen M; Personal Genome Diagnostics, Baltimore, Maryland., Angiuoli SV; Personal Genome Diagnostics, Baltimore, Maryland., Scharpf RB; Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, Maryland., Punt CJA; Department of Medical Oncology, Amsterdam UMC, University of Amsterdam, Amsterdam, the Netherlands.; Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht, the Netherlands., Meijer GA; Department of Pathology, The Netherlands Cancer Institute, Amsterdam, the Netherlands., Velculescu VE; Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, Maryland., Fijneman RJA; Department of Pathology, The Netherlands Cancer Institute, Amsterdam, the Netherlands.
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2023 Mar 01; Vol. 29 (5), pp. 899-909.
Autor:
Keefer LA; Personal Genome Diagnostics Inc., Baltimore, MD, 21224, USA., White JR; Personal Genome Diagnostics Inc., Baltimore, MD, 21224, USA., Wood DE; Personal Genome Diagnostics Inc., Baltimore, MD, 21224, USA., Gerding KMR; Personal Genome Diagnostics Inc., Baltimore, MD, 21224, USA., Valkenburg KC; Personal Genome Diagnostics Inc., Baltimore, MD, 21224, USA., Riley D; Personal Genome Diagnostics Inc., Baltimore, MD, 21224, USA., Gault C; Personal Genome Diagnostics Inc., Baltimore, MD, 21224, USA., Papp E; Personal Genome Diagnostics Inc., Baltimore, MD, 21224, USA., Vollmer CM; Personal Genome Diagnostics Inc., Baltimore, MD, 21224, USA., Greer A; Personal Genome Diagnostics Inc., Baltimore, MD, 21224, USA., Hernandez J; Personal Genome Diagnostics Inc., Baltimore, MD, 21224, USA., McGregor PM 3rd; Personal Genome Diagnostics Inc., Baltimore, MD, 21224, USA., Zingone A; Laboratory of Human Carcinogenesis, Center for Cancer Research, National Cancer Institute, Bethesda, MD, 20850, USA., Ryan BM; Laboratory of Human Carcinogenesis, Center for Cancer Research, National Cancer Institute, Bethesda, MD, 20850, USA., Deak K; Department of Pathology, Duke University School of Medicine, Durham, NC, 27710, USA., McCall SJ; Department of Pathology, Duke University School of Medicine, Durham, NC, 27710, USA., Datto MB; Department of Pathology, Duke University School of Medicine, Durham, NC, 27710, USA., Prescott JL; PathGroup, Nashville, TN, 37217, USA., Thompson JF; Personal Genome Diagnostics Inc., Baltimore, MD, 21224, USA., Cerqueira GC; Personal Genome Diagnostics Inc., Baltimore, MD, 21224, USA., Jones S; Personal Genome Diagnostics Inc., Baltimore, MD, 21224, USA., Simmons JK; Personal Genome Diagnostics Inc., Baltimore, MD, 21224, USA., McElhinny A; Personal Genome Diagnostics Inc., Baltimore, MD, 21224, USA., Dickey J; Personal Genome Diagnostics Inc., Baltimore, MD, 21224, USA., Angiuoli SV; Personal Genome Diagnostics Inc., Baltimore, MD, 21224, USA., Diaz LA Jr; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, 10065, USA., Velculescu VE; Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, MD, 21287, USA., Sausen M; Personal Genome Diagnostics Inc., Baltimore, MD, 21224, USA. msausen@pgdx.com.
Publikováno v:
Nature communications [Nat Commun] 2022 May 20; Vol. 13 (1), pp. 2830. Date of Electronic Publication: 2022 May 20.
Autor:
Vega DM; Friends of Cancer Research, Washington, USA., Yee LM; National Cancer Institute, Bethesda, USA., McShane LM; National Cancer Institute, Bethesda, USA., Williams PM; Molecular Characterization Laboratory, Frederick National Lab for Cancer Research, Leidos Biomedical Research Inc., Frederick, USA., Chen L; Molecular Characterization Laboratory, Frederick National Lab for Cancer Research, Leidos Biomedical Research Inc., Frederick, USA., Vilimas T; Molecular Characterization Laboratory, Frederick National Lab for Cancer Research, Leidos Biomedical Research Inc., Frederick, USA., Fabrizio D; Foundation Medicine Inc., Cambridge, USA., Funari V; NeoGenomics Laboratories, Aliso Viejo, USA., Newberg J; Foundation Medicine Inc., Cambridge, USA., Bruce LK; NeoGenomics Laboratories, Aliso Viejo, USA., Chen SJ; ACT Genomics, Taipei, Taiwan., Baden J; Bristol Myers Squibb Co., Princeton, USA., Carl Barrett J; AstraZeneca Pharmaceuticals LP, Waltham, USA., Beer P; European Organisation for Research and Treatment of Cancer, Brussels, Belgium., Butler M; LGC Clinical Diagnostics, Gaithersburg, USA., Cheng JH; ACT Genomics, Taipei, Taiwan., Conroy J; OmniSeq Inc., Buffalo, USA., Cyanam D; Clinical Sequencing Division, Thermo Fisher Scientific, Ann Arbor, USA., Eyring K; Intermountain Precision Genomics, St. George, USA., Garcia E; Brigham and Women's Hospital, Boston, USA., Green G; Bristol Myers Squibb Co., Princeton, USA., Gregersen VR; QIAGEN Inc, Aarhus, Denmark., Hellmann MD; Memorial Sloan Kettering Cancer Center, New York, USA., Keefer LA; Personal Genome Diagnostics, Baltimore, USA., Lasiter L; Friends of Cancer Research, Washington, USA., Lazar AJ; The University of Texas MD Anderson Cancer Center, Houston, USA., Li MC; National Cancer Institute, Bethesda, USA., MacConaill LE; Brigham and Women's Hospital, Boston, USA., Meier K; Illumina Inc, Clinical Genomics, San Diego, USA., Mellert H; Biodesix, Inc., Boulder, USA., Pabla S; OmniSeq Inc., Buffalo, USA., Pallavajjalla A; Johns Hopkins University, Baltimore, USA., Pestano G; Biodesix, Inc., Boulder, USA., Salgado R; European Organisation for Research and Treatment of Cancer, Brussels, Belgium., Samara R; QIAGEN Inc, Aarhus, Denmark., Sokol ES; Foundation Medicine Inc., Cambridge, USA., Stafford P; Caris Life Sciences Inc, Phoenix, USA., Budczies J; Institute of Pathology, University Hospital Heidelberg, Heidelberg, Germany., Stenzinger A; Institute of Pathology, University Hospital Heidelberg, Heidelberg, Germany., Tom W; Clinical Sequencing Division, Thermo Fisher Scientific, Ann Arbor, USA., Valkenburg KC; Personal Genome Diagnostics, Baltimore, USA., Wang XZ; EMD Serono Research and Development Institute, Inc., Billerica, USA., Weigman V; Q Squared Solutions, Durham, USA., Xie M; AstraZeneca Pharmaceuticals LP, Waltham, USA., Xie Q; General Dynamics Information Technology, Inc., Columbia, USA., Zehir A; Memorial Sloan Kettering Cancer Center, New York, USA., Zhao C; Illumina Inc, Clinical Genomics, San Diego, USA., Zhao Y; National Cancer Institute, Bethesda, USA., Stewart MD; Friends of Cancer Research, Washington, USA. Electronic address: mstewart@focr.org., Allen J; Friends of Cancer Research, Washington, USA.
Publikováno v:
Annals of oncology : official journal of the European Society for Medical Oncology [Ann Oncol] 2021 Dec; Vol. 32 (12), pp. 1626-1636. Date of Electronic Publication: 2021 Oct 01.
Autor:
Deak KL; Department of Pathology, Duke University Medical Center, Durham, North Carolina. Electronic address: kristen.deak@duke.edu., Jackson JB; Personal Genome Diagnostics, Inc., Baltimore, Maryland. Electronic address: jjackson@pgdx.com., Valkenburg KC; Personal Genome Diagnostics, Inc., Baltimore, Maryland., Keefer LA; Personal Genome Diagnostics, Inc., Baltimore, Maryland., Robinson Gerding KM; Personal Genome Diagnostics, Inc., Baltimore, Maryland., Angiuoli SV; Personal Genome Diagnostics, Inc., Baltimore, Maryland., Datto MB; Department of Pathology, Duke University Medical Center, Durham, North Carolina., McCall SJ; Department of Pathology, Duke University Medical Center, Durham, North Carolina.
Publikováno v:
The Journal of molecular diagnostics : JMD [J Mol Diagn] 2021 Oct; Vol. 23 (10), pp. 1324-1333. Date of Electronic Publication: 2021 Jul 24.
Autor:
Roy S; The Johns Hopkins University, The Krieger School of Arts & Sciences, Baltimore, Maryland.; The James Buchanan Brady Urological Institute, Department of Urology, Johns Hopkins University School of Medicine, Baltimore, Maryland., Axelrod HD; The James Buchanan Brady Urological Institute, Department of Urology, Johns Hopkins University School of Medicine, Baltimore, Maryland.; The Cellular and Molecular Medicine Program, Johns Hopkins School of Medicine, Baltimore, Maryland., Valkenburg KC; The James Buchanan Brady Urological Institute, Department of Urology, Johns Hopkins University School of Medicine, Baltimore, Maryland., Amend S; The James Buchanan Brady Urological Institute, Department of Urology, Johns Hopkins University School of Medicine, Baltimore, Maryland., Pienta KJ; The James Buchanan Brady Urological Institute, Department of Urology, Johns Hopkins University School of Medicine, Baltimore, Maryland.
Publikováno v:
Journal of cellular biochemistry [J Cell Biochem] 2019 Apr; Vol. 120 (4), pp. 4804-4812. Date of Electronic Publication: 2018 Nov 02.
Autor:
Axelrod HD; The Cellular and Molecular Medicine Program, Johns Hopkins University, Baltimore, Maryland. haleyaxelrod33@gmail.com.; The James Buchanan Brady Urological Institute, Johns Hopkins University, Baltimore, Maryland., Valkenburg KC; The James Buchanan Brady Urological Institute, Johns Hopkins University, Baltimore, Maryland., Amend SR; The James Buchanan Brady Urological Institute, Johns Hopkins University, Baltimore, Maryland., Hicks JL; The Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, Baltimore, Maryland., Parsana P; Department of Computer Science, Johns Hopkins University, Baltimore, Maryland., Torga G; The James Buchanan Brady Urological Institute, Johns Hopkins University, Baltimore, Maryland., DeMarzo AM; The Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, Baltimore, Maryland.; Departments of Pathology, Urology, and Oncology, The Johns Hopkins School of Medicine, Johns Hopkins University, Baltimore, Maryland., Pienta KJ; The James Buchanan Brady Urological Institute, Johns Hopkins University, Baltimore, Maryland.
Publikováno v:
Molecular cancer research : MCR [Mol Cancer Res] 2019 Feb; Vol. 17 (2), pp. 356-369. Date of Electronic Publication: 2018 Oct 05.
Autor:
van der Toom EE; Department of Urology, Amsterdam UMC, Amsterdam, Netherlands., Axelrod HD; The James Buchanan Brady Urological Institute, Baltimore, MD, USA.; Graduate Program in Cellular and Molecular Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, USA., de la Rosette JJ; Department of Urology, Istanbul Medipol University, Istanbul, Turkey., de Reijke TM; Department of Urology, Amsterdam UMC, Amsterdam, Netherlands., Pienta KJ; The James Buchanan Brady Urological Institute, Baltimore, MD, USA., Valkenburg KC; The James Buchanan Brady Urological Institute, Baltimore, MD, USA. kvalken1@jhmi.edu.
Publikováno v:
Nature reviews. Urology [Nat Rev Urol] 2019 Jan; Vol. 16 (1), pp. 7-22.